Volume 27 Issue 11
Nov.  2019
Turn off MathJax
Article Contents

WU Jing, NORRIS Jessie, LIU Hui Xin, LI Zheng, SU Ying Ying, ZHU Lin, WANG Ning. The Prevalence of HIV Drug Resistance among Treatment-failure Individuals and Treatment-na?ve Individuals in China:A Meta-analysis[J]. Biomedical and Environmental Sciences, 2014, 27(11): 858-871. doi: 10.3967/bes2014.123
Citation: WU Jing, NORRIS Jessie, LIU Hui Xin, LI Zheng, SU Ying Ying, ZHU Lin, WANG Ning. The Prevalence of HIV Drug Resistance among Treatment-failure Individuals and Treatment-na?ve Individuals in China:A Meta-analysis[J]. Biomedical and Environmental Sciences, 2014, 27(11): 858-871. doi: 10.3967/bes2014.123

The Prevalence of HIV Drug Resistance among Treatment-failure Individuals and Treatment-na?ve Individuals in China:A Meta-analysis

doi: 10.3967/bes2014.123
Funds:  This study is supported by the National Megaprojects of Science Research for the 12th Five-Year Plan (2012ZX10001-001)
  • Objective To understand drug resistance prevalence among treatment-failure and treatment-na?ve HIV-positive individuals in China.
    Methods We searched five electronic databases (Wanfang, CNKI, CQVIP, SinoMed, and Pubmed) for studies of HIV drug resistance. Random-effects models were carried out to estimate the prevalence of drug resistance among treatment-failure and treatment-na?ve individuals, respectively.
    Results The estimated nationwide rates of HIV drug resistance to any-class drugs among treatment-failure and treatment-na?ve individuals were 57% (95% CI: 49%-65%) and 3.23% (95% CI:2.47%-4.07%), respectively. Among the drug classes, the prevalence of resistance to PIs was low (1.45%;95%CI:0.73%-2.33%) in treatment-failure individuals, although high rates of resistance to NNRTIs (54%;95%CI:45%-63%) and NRTIs (40%;95%CI:32%-49%) were found. Resistance to any-class drugs, NNRTIs and NRTIs manifested regional differences, but resistance to PIs did not. Positive correlations were observed between resistance to NNRTIs and NRTIs among treatment-failure and treatment-na?ve individuals, respectively.
    Conclusion The prevalence of HIV drug resistance to NNRTIs and NRTIs among treatment-failure individuals was high. In contrast, the prevalence of drug resistance among treatment-na?ve individuals was low. The epidemics of drug resistance matched current treatment strategies and interventions in China. Surveillance for HIV drug resistance is necessary to assess the sustainability and durability of current treatment regimens.
  • 加载中
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(660) PDF downloads(61) Cited by()

Proportional views
Related

The Prevalence of HIV Drug Resistance among Treatment-failure Individuals and Treatment-na?ve Individuals in China:A Meta-analysis

doi: 10.3967/bes2014.123
Funds:  This study is supported by the National Megaprojects of Science Research for the 12th Five-Year Plan (2012ZX10001-001)

Abstract: Objective To understand drug resistance prevalence among treatment-failure and treatment-na?ve HIV-positive individuals in China.
Methods We searched five electronic databases (Wanfang, CNKI, CQVIP, SinoMed, and Pubmed) for studies of HIV drug resistance. Random-effects models were carried out to estimate the prevalence of drug resistance among treatment-failure and treatment-na?ve individuals, respectively.
Results The estimated nationwide rates of HIV drug resistance to any-class drugs among treatment-failure and treatment-na?ve individuals were 57% (95% CI: 49%-65%) and 3.23% (95% CI:2.47%-4.07%), respectively. Among the drug classes, the prevalence of resistance to PIs was low (1.45%;95%CI:0.73%-2.33%) in treatment-failure individuals, although high rates of resistance to NNRTIs (54%;95%CI:45%-63%) and NRTIs (40%;95%CI:32%-49%) were found. Resistance to any-class drugs, NNRTIs and NRTIs manifested regional differences, but resistance to PIs did not. Positive correlations were observed between resistance to NNRTIs and NRTIs among treatment-failure and treatment-na?ve individuals, respectively.
Conclusion The prevalence of HIV drug resistance to NNRTIs and NRTIs among treatment-failure individuals was high. In contrast, the prevalence of drug resistance among treatment-na?ve individuals was low. The epidemics of drug resistance matched current treatment strategies and interventions in China. Surveillance for HIV drug resistance is necessary to assess the sustainability and durability of current treatment regimens.

WU Jing, NORRIS Jessie, LIU Hui Xin, LI Zheng, SU Ying Ying, ZHU Lin, WANG Ning. The Prevalence of HIV Drug Resistance among Treatment-failure Individuals and Treatment-na?ve Individuals in China:A Meta-analysis[J]. Biomedical and Environmental Sciences, 2014, 27(11): 858-871. doi: 10.3967/bes2014.123
Citation: WU Jing, NORRIS Jessie, LIU Hui Xin, LI Zheng, SU Ying Ying, ZHU Lin, WANG Ning. The Prevalence of HIV Drug Resistance among Treatment-failure Individuals and Treatment-na?ve Individuals in China:A Meta-analysis[J]. Biomedical and Environmental Sciences, 2014, 27(11): 858-871. doi: 10.3967/bes2014.123

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return